# SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment

> **NCT07145190** · — · RECRUITING · sponsor: **Bial - Portela C S.A.** · enrollment: 90 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** SL-APO

## Key facts

- **NCT ID:** NCT07145190
- **Lead sponsor:** Bial - Portela C S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-27
- **Primary completion:** 2028-02
- **Final completion:** 2028-02
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07145190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07145190, "SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07145190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*